Consistent with this KIT-MEK-ETV1 signalling pathway model, the overlap between genes transcriptionally altered by imatinib treatment (KIT-regulated) and by ETV1 knockdown in GIST882 cells is highly significant ( Fig. 4c ).
← all excerpts
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.
1
—
—